LEADER 01111nam0-2200349---450-
001 990008785310403321
005 20090901182638.0
010   $a0-306-40302-1
035   $a000878531
035   $aFED01000878531
035   $a(Aleph)000878531FED01
035   $a000878531
100   $a20081223d1979----km-y0itay50------ba
101 1 $aeng
102   $aUS
105   $aa-------001yy
200 1 $aNucleoside analogues$echemistry, biology, and medical applications$fedited by Richard T. Walker, Erik de Clercq, and Fritz Eckstein
210   $aNew York$cPlenum press$d1979
215   $ax, 459 p.$cill.$d26 cm
225 1 $aNATO ASI series$hSeries A$iLife sciences$v26
676   $a615$v19
702  1$aWalker,$bRichard T.$c<chimico>
702  1$aDe Clercq,$bErik
702  1$aEckstein,$bFritz
710 12$aNATO Advanced Study Institute on Nucleoside Analogues$f<1979 ;$eSogesta>$0316414
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008785310403321
952   $aC 8b 12$b1782/CB1$fDMBBM
959   $aDMBBM
996   $aNucleoside analogues$9809358
997   $aUNINA